Specialty biopharma Shire has extended its relationship with Medidata Solutions by signing on for multiyear use of the Grants Manager and CRO Contractor trial planning products. Shire researchers will to able to continue providing high-level cost forecasting and budget management as well as cost planning management.
Shire, a developer of human genetic therapies for attention deficit and hyperactivity disorders and gastrointestinal diseases, will also implement three analysis modules that aid in managing clinical research costs and clinical development processes. According to an announcement, Shire has added a full-time position dedicated to providing quality assurance of the trial planning and budgeting process to optimize its use of the software tools.
The drug developer has used Grants Manager and CRO Contractor for more than four years, the announcement says. The contract extension follows a process evaluation and the development of improvements to the biotech's global trial budgeting and costing approaches.
- read the release